The Discounted Cash Flow (DCF) valuation of Seoul Pharma Co Ltd (018680.KQ) is 4,269.63 KRW. With the latest stock price at 3,565.00 KRW, the upside of Seoul Pharma Co Ltd based on DCF is 19.8%.
Based on the latest price of 3,565.00 KRW and our DCF valuation, Seoul Pharma Co Ltd (018680.KQ) is a buy. buying 018680.KQ stocks now will result in a potential gain of 19.8%.
| Range | Selected | |
| WACC / Discount Rate | 5.4% - 7.1% | 6.2% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | 2,918.22 - 7,733.20 | 4,269.63 |
| Upside | -18.1% - 116.9% | 19.8% |